Lalit R. Patel

3.7k citations

26 papers · 2.3k indexed · 1 hit paper · h-index 18

Oncology top 2%
Molecular Biology top 10%
Cancer Research top 2%
Immunology top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Kenneth J. Pienta Russell S. Taichman Yusuke Shiozawa Jian Zhang Jingcheng Wang Aaron M. Havens Younghun Jung Elisabeth A. Pedersen
Topics: Cancer Cells and Metastasis (4 papers)Immunotherapy and Immune Responses (3 papers)Cancer-related molecular mechanisms research (3 papers)
Cited by: Cancer Research Oncology Immunology
Journals: Journal of Clinical InvestigationSHILAP Revista de lepidopterologíaMolecular Cell
Partner nations: United States South Korea Belgium

In The Last Decade

Lalit R. Patel

26 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow

2011 534 citations Yusuke Shiozawa, Elisabeth A. Pedersen et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Lalit R. Patel

Since Specialization

Citations

This map shows the geographic impact of Lalit R. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lalit R. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lalit R. Patel more than expected).

Fields of papers citing papers by Lalit R. Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lalit R. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lalit R. Patel. The network helps show where Lalit R. Patel may publish in the future.

Co-authorship network of co-authors of Lalit R. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Lalit R. Patel. A scholar is included among the top collaborators of Lalit R. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lalit R. Patel. Lalit R. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Progress in personalized immunotherapy for patients with brain metastasis 2025 ·npj Precision Oncology ·Lalit R. Patel,Nikola Kolundžić,Malak Abedalthagafi	6
2	p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator 2024 ·Cancer Research Communications ·(unknown),(unknown),Denada Dibra,Lalit R. Patel,Shunbin Xiong,Yun Zhang,Gilda P. Chau,Xiaoping Su,Yuan Qi,Adel K. El‐Naggar,Guillermina Lozano	1
3	Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants 2023 ·Cancer Research ·Dhruv Chachad,Lalit R. Patel,(unknown),Rasoul Pourebrahim,Elizabeth M. Whitley,Wenyi Wang,Xiaoping Su,An Xu,Dung‐Fang Lee,Guillermina Lozano	6
4	Genome-wide CRISPR-Cas9 screen analyzed by SLIDER identifies network of repressor complexes that regulate TRIM24 2023 ·iScience ·Lalit R. Patel,Sabrina A. Stratton,Megan M. McLaughlin,(unknown),Kendra Allton,(unknown),(unknown),Traver Hart,Michelle Barton	1
5	LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56 2016 ·Molecular Cell ·Abhinav K. Jain,Yuanxin Xi,Ryan L. McCarthy,Kendra Allton,Kadir C. Akdemir,Lalit R. Patel,Bruce J. Aronow,Chunru Lin,Wei Li,Liuqing Yang,Michelle Barton	169
6	Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1α and Oxidative Phosphorylation in Melanoma 2014 ·Cancer Research ·Y.N. Vashisht Gopal,Helen Rizos,Guo Chen,Wanleng Deng,Dennie T. Frederick,Zachary A. Cooper,Richard A. Scolyer,Gulietta M. Pupo,Kakajan Komurov,Vasudha Sehgal,Jiexin Zhang,Lalit R. Patel,Cristiano Gonçalves Pereira,Bradley M. Broom,Gordon B. Mills,Prahlad T. Ram,Paul D. Smith,Jennifer A. Wargo,Georgina V. Long,Michael A. Davies	148
7	The lncRNA PCAT29 Inhibits Oncogenic Phenotypes in Prostate Cancer 2014 ·Molecular Cancer Research ·Rohit Malik,Lalit R. Patel,John R. Prensner,Yang Shi,Matthew K. Iyer,(unknown),(unknown),Yashar S. Niknafs,Anirban Sahu,Sumin Han,Teng Ma,Meilan Liu,Irfan A. Asangani,Xiaojun Jing,Xuhong Cao,Saravana M. Dhanasekaran,Dan R. Robinson,Felix Y. Feng,Arul M. Chinnaiyan	112
8	Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma 2014 ·JNCI Journal of the National Cancer Institute ·Yuexin Liu,Lalit R. Patel,Gordon B. Mills,Karen H. Lu,Anil K. Sood,Li Ding,Raju Kucherlapati,Elaine R. Mardis,Douglas A. Levine,Ilya Shmulevich,Russell R. Broaddus,Wei Zhang	166
9	GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor Formation 2013 ·PLoS ONE ·Russell S. Taichman,Lalit R. Patel,(unknown),Jingcheng Wang,(unknown),(unknown),Kenji Yumoto,Janice E. Berry,Yusuke Shiozawa,Kenneth J. Pienta	102
10	Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution 2012 ·Cancer Letters ·Lalit R. Patel,Matti Nykter,Kexin Chen,Wei Zhang	18
11	Prevalence of Prostate Cancer Metastases after Intravenous Inoculation Provides Clues into the Molecular Basis of Dormancy in the Bone Marrow Microenvironment 2012 ·Neoplasia ·Younghun Jung,Yusuke Shiozawa,Jingcheng Wang,Natalie McGregor,Jinlu Dai,Serk In Park,Janice E. Berry,Aaron M. Havens,Jeena Joseph,Jin Koo Kim,Lalit R. Patel,Peter Carmeliet,Stephanie Daignault,Evan T. Keller,Laurie K. McCauley,Kenneth J. Pienta,Russell S. Taichman	50
12	384 hanging drop arrays give excellent Z‐factors and allow versatile formation of co‐culture spheroids 2011 ·Biotechnology and Bioengineering ·Amy Y. Hsiao,Yi‐Chung Tung,Xianggui Qu,Lalit R. Patel,Kenneth J. Pienta,Shuichi Takayama	108
13	Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowbreakdown → 2011 ·Journal of Clinical Investigation ·Yusuke Shiozawa,Elisabeth A. Pedersen,Aaron M. Havens,Younghun Jung,Anjali Mishra,Jeena Joseph,Jin Koo Kim,Lalit R. Patel,Ying Chi,(unknown),Michael J. Pienta,Junhui Song,Jingcheng Wang,Robert D. Loberg,Paul H. Krebsbach,Kenneth J. Pienta,Russell S. Taichman	534
14	Nanoparticle Induced Cell Magneto-Rotation: Monitoring Morphology, Stress and Drug Sensitivity of a Suspended Single Cancer Cell 2011 ·PLoS ONE ·(unknown),Brandon H. McNaughton,Lalit R. Patel,Kenneth J. Pienta,Raoul Kopelman	31
15	Targeting Chemokine (C-C motif) Ligand 2 (CCL2) as an Example of Translation of Cancer Molecular Biology to the Clinic 2010 ·Progress in molecular biology and translational science ·Jian Zhang,Lalit R. Patel,Kenneth J. Pienta	79
16	Prospective Identification and Skeletal Localization of Cells Capable of Multilineage Differentiation In Vivo 2010 ·Stem Cells and Development ·Russell S. Taichman,Zhuo Wang,Yusuke Shiozawa,Younghun Jung,Junhui Song,Alex Balduíno,Jincheng Wang,Lalit R. Patel,Aaron M. Havens,Magda Kucia,Mariusz Z. Ratajczak,Paul H. Krebsbach	74
17	GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche 2010 ·Neoplasia ·Yusuke Shiozawa,Elisabeth A. Pedersen,Lalit R. Patel,(unknown),Aaron M. Havens,Younghun Jung,Jingcheng Wang,(unknown),Robert D. Loberg,Kenneth J. Pienta,Russell S. Taichman	252
18	Annexin-2 is a regulator of stromal cell-derived factor–1/CXCL12 function in the hematopoietic stem cell endosteal niche 2010 ·Experimental Hematology ·Younghun Jung,Yusuke Shiozawa,Jingcheng Wang,Lalit R. Patel,Aaron M. Havens,Junhui Song,Paul H. Krebsbach,G. David Roodman,Russell S. Taichman	44
19	AT‐101 (R‐(−)‐gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model 2010 ·Journal of Cellular Biochemistry ·Natalie McGregor,Lalit R. Patel,Matthew Craig,(unknown),Shaomeng Wang,Kenneth J. Pienta	20
20	CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis 2009 ·Cytokine & Growth Factor Reviews ·Jian Zhang,Lalit R. Patel,Kenneth J. Pienta	217

About Lalit R. Patel

Lalit R. Patel is a scholar working on Cancer Research, Oncology and Immunology, having authored 26 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (660 citations), Oncology (1.1k citations) and Immunology (451 citations). Lalit R. Patel has collaborated with scholars based in United States, South Korea and Belgium. Frequent co-authors include Kenneth J. Pienta, Russell S. Taichman, Yusuke Shiozawa, Jian Zhang, Jingcheng Wang, Aaron M. Havens, Younghun Jung, Elisabeth A. Pedersen, Robert D. Loberg and Paul H. Krebsbach. Their work appears in journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact